GTS Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
GTS Securities's MRNA Position: Q3 2026 in Review
GTS Securities opened a new position in Moderna (MRNA) in Q3 2026: 3,340 shares worth $643K. The stake represents 0.01% of the portfolio and ranks #750 among its holdings. This is a return to the name: GTS Securities previously reported a position in MRNA as recently as Q1 2025.
GTS Securities first reported a position in MRNA in Q2 2023 and has held it in 8 quarters since. The position peaked at $16M in Q3 2023. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- GTS Securities held 3,340 shares of Moderna worth $643K as of Q3 2026.
- Moderna was a new GTS Securities position in Q3 2026.
- Moderna made up 0.01% of GTS Securities's portfolio in Q3 2026, its #750 holding.
- GTS Securities first reported a position in Moderna in Q2 2023 and has held it in 8 quarters since.
- GTS Securities's Moderna position peaked at $16M in Q3 2023.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.